Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Items 601–700 of 727
Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma
Nagane, M., Huang, H., & Cavenee, W. K. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0062 · Cited by 8
Nishikawa, R., & Matsutani, M. (1998) · Neurosurgical FOCUS · doi:10.3171/foc.1998.5.1.5 · Cited by 8
Does Apoptosis Contribute to Tumor Cell Sensitivity to Anticancer Agents?
Brown, J. M., & Wouters, B. G. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_1 · Cited by 8
Quantitative Fluorescence Imaging Approach for the Study of Polyploidization in Hepatocytes
Lamas, E., Chassoux, D., Decaux, J., Bréchot, C., & Debey, P. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100307 · Cited by 8
Sengupta, S., Ralhan, R., & Wasylyk, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203256 · Cited by 8
Shinohara, H., Zhou, J., Yoshikawa, K., Yazumi, S., Ko, K. H., Yamaoka, Y., Mizukami, T., Yoshida, T., Akinaga, S., Tamaoki, T., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1411 · Cited by 7
Wu, Y., Hour, M. J., Leung, W. C., Wu, C., Liu, W. Z., Chang, Y., & Lee, H. Z. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176115 · Cited by 7
p21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives
Tillhon, M., Cazzalini, O., Dutto, I., Lucia, A., & Prosperi, E. (2013) · InTech eBooks · doi:10.5772/54173 · Cited by 7
Ryu, S. Y., Kim, K., Lee, W. S., Kwon, H. C., Lee, K. H., Kim, C. M., & Kang, S. (2009) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2009.20.1.48 · Cited by 7
Chen, G., & Hitomi, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4484 · Cited by 8
Metastatic Bladder Cancer: Role of Chemotherapy and New Agents
Sternberg, C. N. (2003) · EAU Update Series · doi:10.1016/s1570-9124(03)00019-9 · Cited by 7
Siddik, Z. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_16 · Cited by 8
Attalla, H., Mäkelä, T. P., Wähälä, K., Rasku, S., Andersson, L. C., & Adlercreutz, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7495 · Cited by 7
Goto, D., Izumi, H., Ono, M., Okamoto, T., Kohno, K., & Kuwano, M. (1998) · Angiogenesis · doi:10.1023/a:1009252811114 · Cited by 7
Cunningham, C. E., Vizeacoumar, F. S., Zhang, Y., Kyrylenko, L., Both, S., Maranda, V., Dong, H., Price, J. D. W., Gao, P., Wagner, K., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100876 · Cited by 11
Aiello, K. A., Ponnapalli, S. P., & Alter, O. (2018) · APL Bioengineering · doi:10.1063/1.5037882 · Cited by 5
p14ARFinduces apoptosisviaan entirely caspase-3-dependent mitochondrial amplification loop
Milojkovic, A., Hemmati, P., Müer, A., Overkamp, T., Chumduri, C., Jänicke, R. U., Gillissen, B. F., & Daniel, P. T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28279 · Cited by 7
Milgrom, S. A., & García‐Aguilar, J. (2013) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2013.03.003 · Cited by 7
Effect of X-rays on expression of caspase-3 and p53 in EL-4 cells and its biological implications.
Ju, G., Shen, B., Sun, S., Yan, F., & Fu, S. (2007) · PubMed · Cited by 6
Molecular characterization of an MLL1 fusion and its role in chromosomal instability
Parameswaran, S., Vizeacoumar, F. S., Bhanumathy, K. K., Qin, F., Islam, M. F., Toosi, B. M., Cunningham, C. E., Mousseau, D. D., Uppalapati, M., Stirling, P. C., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12423 · Cited by 6
Zimmermann, S., Biniossek, M. L., Maurer, C., Münzer, P., Pantić, M., Veelken, H., & Martens, U. M. (2009) · PROTEOMICS · doi:10.1002/pmic.200900232 · Cited by 7
Daniel, P. T. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_5 · Cited by 12
DNA replication and smooth muscle cell hypertrophy
Walsh, K., Shiojima, I., & Gualberto, A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8203 · Cited by 6
Molecular Targets in Gastric Cancer and Apoptosis
Balcer‐Kubiczek, E. K., & Garofalo, M. C. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9_7 · Cited by 5
Talbert, D. R., Wappel, R. L., Moran, D. M., Shell, S. A., & Bacus, S. S. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.44102 · Cited by 5
Herriage, H. C., Hughes, C. L., Fahey, S. K., & Calvi, B. R. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218008 · Cited by 5
Lu, Y., Takebe, H., & Yagi, T. (2000) · Journal of Radiation Research · doi:10.1269/jrr.41.341 · Cited by 5
Ponnapalli, S. P., Bradley, M. W., Devine, K., Bowen, J., Coppens, S. E., Leraas, K., Milash, B. A., Li, F., Luo, H., Qiu, S., et al. (2020) · APL Bioengineering · doi:10.1063/1.5142559 · Cited by 5
Human Somatic Cell Gene Targeting
Waldman, T. A., Lee, C. S., Nishanian, T. G., & Kim, J. (2003) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0915s62 · Cited by 5
Self-citationMVAC chemotherapy-induced apoptosis and p53 alterations in the rat model of bladder cancer
Zhang, X., Jin, L., & Takenaka, I. (1998) · Urology · doi:10.1016/s0090-4295(98)00364-1 · Cited by 5
Smirnova, I. S., Yakovleva, T. K., Rosanov, Y. M., Aksenov, N. D., & Pospelova, T. V. (2001) · Cell Biology International · doi:10.1006/cbir.2001.0709 · Cited by 5
Hypoxia inhibition of camptothecin-induced apoptosis by Bax loss
Park, K., Abdela, W., Fermin, C. D., Reddy, G., Habtemariam, T., Chung, J. W., Park, M., Seol, D., & Kim, M. (2012) · Biologia · doi:10.2478/s11756-012-0037-6 · Cited by 6
Lodygin, D., Menssen, A., & Hermeking, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216588 · Cited by 11
Expression of P21WAF1/CIP1/SID1 cyclin-dependent kinase inhibitor in hematopoietic progenitor cells
Campanini, F., Santucci, M. A., Brusa, G., Pattacini, L., Arpinati, M., Rondelli, D., Gamberi, B., Barbieri, E., Babini, L., & Tura, S. (2001) · Gene · doi:10.1016/s0378-1119(01)00594-7 · Cited by 5
Expression of Bcl‐2 and Bax in oligodendrogliomas and their relationship to apoptosis
Delgado, Anderson, Whittle, & Wharton (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00199.x · Cited by 5
Waldman, T. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1972 · Cited by 4
Self-citationLee, S. K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.950 · Cited by 4
Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2
Wang, R., Liu, F., Zhao, Y., Wu, D., Chen, L., Yeh, E. T. H., & Huang, C. (2017) · Oncotarget · doi:10.18632/oncotarget.19594 · Cited by 6
Mechanisms of resistance to alkylating agents
Damia, G. L. M., & D’Incalci, M. (1998) · Springer eBooks · doi:10.1007/978-94-017-2374-9_10 · Cited by 4
Role of the RNA-Binding Protein HuR in Apoptosis and Apoptosome Function
Kuwano, Y., Gallouzi, I., & Gorospe, M. (2009) · Springer eBooks · doi:10.1007/978-90-481-3415-1_10 · Cited by 5
Therapeutic manipulation of apoptosis in cancer and neurological disease
Watson, A. J. M., & Lowenstein, P. R. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5287-1_10 · Cited by 4
Mohamed, A. R. (2024) · ERU Research Journal · doi:10.21608/erurj.2024.220125.1047 · Cited by 3
Fuessel, S., Kunze, D., & Manfred, P. W. (2012) · InTech eBooks · doi:10.5772/30276 · Cited by 4
Cell Cycle and DNA Damage Response in Postmitotic Neurons
Kruman, I. I. (2011) · InTech eBooks · doi:10.5772/20859 · Cited by 4
Yamasaki, F., Kajiwara, Y., Hama, S., Murakami, T., Hidaka, T., Saito, T., Yoshioka, H., Sugiyama, K., Arita, K., & Kurisu, K. (2007) · Pathobiology · doi:10.1159/000101048 · Cited by 3
Cell Cycle Inhibitors and Outcome after Radiotherapy in Bladder Cancer Patients
Røtterud, R., Pettersen, E. O., Berner, A., Holm, R., Olsen, D. R., & Fosså, S. D. (2002) · Acta Oncologica · doi:10.1080/028418602320405069 · Cited by 3
Tumour Genotype and Response to Cytotoxic Gene Therapy
Daniel, P. T., Gillissen, B., & Sturm, I. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1353-7_5 · Cited by 3
Yamauchi, Y., Tanaka, A., Yamaguchi, K., Kobayashi, M., Shimamura, S., & Hanaoka, F. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3841 · Cited by 3
Khanna, S. J., Brown, R., Whetton, A. D., Ball, K. L., & Dive, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007073200 · Cited by 5
Houghton, P. J. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-725-3_21 · Cited by 3
Cancer Gene Therapy with Tumor Suppressor Genes Involved in Cell-Cycle Control
Meng, R. D., & El‐Deiry, W. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50018-5 · Cited by 3
Senescence and Cellular Immortality
Demaria, M., & Velarde, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65016-x · Cited by 2
Andrade, M. J., Lonkhuyzen, D. R. V., Upton, Z., & Satyamoorthy, K. (2021) · Journal of Cell Science · doi:10.1242/jcs.255786 · Cited by 2
The molecular genetics of colonic cancer
Augenlicht, L. H. (1998) · Cancer treatment and research · doi:10.1007/978-1-4615-4977-2_13 · Cited by 4
Tateishi, S., & Yamaizumi, M. (1997) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02674279 · Cited by 2
Wolff, G., Schumacher, A., Nussler, A. K., Ruppert, V., Karawajew, L., Wehnes, E., Neuhaus, P., & Dörken, B. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301864 · Cited by 2
Modeling Human Colorectal Cancer in Mice for Chemoprevention Studies
Lipkin, M., & Lamprecht, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59259-768-0_4 · Cited by 2
p53, Apoptosis, and Chemosensitivity
Lowe, S. W. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_2 · Cited by 2
Mammalian Cell-Cycle Responses to DNA-Damaging Agents
Rowley, R. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-455-9_21 · Cited by 2
p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients
Ooi, L. C., Ho, V., Zhu, J. Z., Lim, S. H.-S., Chung, L., Abubakar, A., Rutland, T., Chua, W. M., Ng, W. L., Lee, M. T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020725 · Cited by 3
Sun, J., Zhang, Z., Yu, Y., Cruz, N., Zhang, S., Xiang, Y., Ito, K., Lazarus, C., Tang, Z., Li, B., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.05.006 · Cited by 1
Gamma Radiation Induces p53-Mediated Cell Cycle Arrest in Bone Marrow Cells
Moraes, A. A. F. S., Lucimar, P., Vanina, M., Lasakosvitsch, F., Gaiba, S., Azevedo, F. L. A., Amanda, P. A., Segreto, H. R. C., Alice, T., & Jeronimo, P. (2012) · InTech eBooks · doi:10.5772/38522 · Cited by 1
Goto, S., Murakami, M., Waseda, M., SAWATANI, T., Satō, A., Otsuka, K., Makita, H., Narita, K., Fukoue, Y., Kato, T., et al. (2004) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms1989.16.161 · Cited by 1
Studi, D., Milano-Bicocca, D., Gaglio, D., & Chiaradonna, F. (2009) · Cited by 1
New insights into the kinetic resistance to anticancer agents
Chauffert, B., Dimanche‐Boitrel, M., Garrido, C., Ivarsson, M., Martin, M. S., Martin, F., & Solary, É. (1998) · Springer eBooks · doi:10.1007/978-94-017-2374-9_14 · Cited by 1
Jun, D. Y., & Kim, Y. H. (2016) · Journal of Life Science · doi:10.5352/jls.2016.26.3.376 · Cited by 1
Rb deficiency induces p21cip1 expression and delays retinal degeneration in rd1 mice
Lv, Z., Xiao, L., Tang, Y., Chen, Y., & Chen, D. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108701 · Cited by 3
Decisiones en los macrófagos: proliferar, activarse o morir.
Comalada, M. (2002) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Pharmakogenomik maligner Tumoren
Daniel, P. T., Sturm, I., Hemmati, P., & G�ner, D. (2004) · Der Onkologe · doi:10.1007/s00761-003-0628-5 · Cited by 1
Chapusot, C., Assem, M., Martin, L., Chalabreyssse, L., Benhamiche, A. M., Lignier, M. A., Chauffert, B., Teyssier, J., Faivre, J., & Piard, F. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(00)00015-8 · Cited by 1
The evolving role of chemotherapy in advanced urothelial cancer
Calabrò, F., & Sternberg, C. N. (2007) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3282f1aad1 · Cited by 1
Mateos, S., Domı́nguez, I., Cantero, G., Pastor, N., Campanella, C., & Cortés, F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.06.007 · Cited by 1
Molecular mode of action and mechanism of resistance of the microtubule- stabilizing drug Sagopilone
Winsel, S. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12573 · Cited by 1
Smith, N. D., Rubenstein, J. N., Eggener, S. E., & Kozlowski, J. M. (2003) · Cited by 1
Targeting p21-Dependent Pathways for Cell Death in Cancer Therapy
Siddik, Z. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_13 · Cited by 1
Daniel, P. T., Sturm, I., Hemmati, P., & Güner, D. (2004) · Cited by 1
Kommoss, F. K. F., & Ridder, R. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57533-4_16 · Cited by 1
Synthetic inhibitors of yeast cyclin-dependent kinase-activating kinases as antifungal agents
(2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.6.925 · Cited by 1
Nakouzi, N. A. (2011) · theses.fr (ABES) · doi:10.70675/4e4b277az83fbz4562zbae0z9f48206f14aa · Cited by 1
Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50006-6
The Role and Regulation of p21 in Myelopoiesis
Ghanem, L. R. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Egler, V. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005031509
Tumor Markers of Neo-Adjuvant Chemo-Radiation Response in Rectal Cancer
Jacintha, N., Clare, M., & John, V. (2011) · InTech eBooks · doi:10.5772/28095
The Level of ROS and DNA Damage Mediate with the Type of Cell Death, Senescence or Apoptosis
Inoue, T., & Wake, N. (2012) · InTech eBooks · doi:10.5772/33035
Bharadwaj, A. G. (2009) · Lincoln (University of Nebraska)
Soy Metabolites, Isoflavones in Cell Growth and Apoptosis
Sarkar, F. H. (1999) · doi:10.21236/ada374128
Analysis of stem cell genome stability and cancer-associated developmental programmes
Aizeer, K. I. (2011) · Bangor University Research Portal (Bangor University)
Trifunovic-Rakic, T. (2009) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21254
Lerner, S. P., & Raghavan, D. (2001) · Current clinical urology · doi:10.1007/978-1-59259-097-1_11
Hütter, G. (2000) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/14467
Review : p53 in the pathogenesis, diagnosis, and treatment of cancer
Perz, E., & Kuhn, J. G. (1998) · Journal of Oncology Pharmacy Practice · doi:10.1177/107815529800400201 · Cited by 1
Zo, J. H. (2001) · Korean Circulation Journal · doi:10.4070/kcj.2001.31.1.63
Clinical value of molecular changes in ovarian carcinoma
Kupryjańczyk, J. (2004) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/s1507-1367(04)71021-4
Molecular Biology of Urothelial Cancer
Gupta, S., & Hansel, D. E. (2014) · Springer eBooks · doi:10.1007/978-0-85729-482-1_33
DNA damage-induced cell death : The role of caspase-2
Vakifahmetoglu, H. (2009) · Figshare
CARDINAL REGENERATIVE FEATURES OF THE MRL MOUSE — AN UPDATE
Arthur, L. M., Sachadyn, P., Gourevitch, D., & Heber‐Katz, E. (2011) · Gene Therapy and Regulation · doi:10.1142/s1568558611000246
New perspectives on the genetics of male infertility
Dada, R., Venkatesh, S., Kumar, M., Kumar, R., Tanwar, M., Pathak, D., Sharma, A., & Shamsi, M. B. (2009)
Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing
Chiang, C.-T., Way, T., & Lin, J. (2007)
EDITORIALS Reflections on Breast Self-examination
Baines, C. J. (2015)
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.